GlassScriptPhysician profile
Arielle J Wiley
NPI 1851826507
$5,713.88
in general payments reported to CMS, 2019-2025
18 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $290 · 2023: $2,463 · 2024: $1,901 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,795 · Food and Beverage: $1,529 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,795.00 |
| Food and Beverage | $1,529.32 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $4,391.11 | 2022-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $300.59 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $190.22 | 2023-2024 | Acessa Provu System, Coolseal Generator, Omni Hysteroscope |
| Pfizer INC. | $160.00 | 2022-2024 | |
| Exeltis, USA INC. | $136.92 | 2023-2025 | Slynd |
| Novo Nordisk INC | $124.81 | 2024-2025 | Wegovy |
| Myovant Sciences INC. | $81.30 | 2022 | |
| Abbvie INC. | $62.22 | 2022-2024 | |
| Lilly USA, LLC | $56.35 | 2025 | Zepbound |
| Medtronic, INC. | $51.34 | 2024 | Abre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.31 | 2022 | |
| Dexcom, INC. | $24.22 | 2023 | Dexcom G6 Transmitter |
| Scynexis, INC. | $22.21 | 2022 | |
| Mayne Pharma Commercial LLC | $19.83 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.28 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $17.97 | 2023 | Gattex |
| Gynesonics, INC. | $16.37 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Currax Pharmaceuticals LLC | $14.83 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arielle Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.